StockNews.com downgraded shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Rating) from a hold rating to a sell rating in a research note published on Monday morning. A number of other analysts have also recently issued reports on the company. HC Wainwright lowered their target price on Syros Pharmaceuticals from $100.00 to $60.00 and set a […]
$5 65 Million in Sales Expected for Syros Pharmaceuticals, Inc (NASDAQ:SYRS) This Quarter etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.